MLchartDataset catalogue

CXCR2 agonist MGTA-145

Term · Oncology and biomedicine · MLC-T-ONC-012844

An agonist of CXC chemokine receptor type 2 (CXCR2), with potential hematopoietic stem cell (HSC) mobilization activity. Upon administration, CXCR2 agonist MGTA-145 binds to and activates CXCR2. This releases matrix metalloproteinase-9 (MMP-9), resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. The HSCs can be collected for autologous and allogeneic stem cell transplantation.

Table 1. Record
IdentifierMLC-T-ONC-012844
FieldOncology and biomedicine
SynonymsGRO-beta; GROb
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012844",
  "term": "CXCR2 agonist MGTA-145",
  "field": "Oncology and biomedicine",
  "definition": "An agonist of CXC chemokine receptor type 2 (CXCR2), with potential hematopoietic stem cell (HSC) mobilization activity. Upon administration, CXCR2 agonist MGTA-145 binds to and activates CXCR2. This releases matrix metalloproteinase-9 (MMP-9), resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation. The HSCs can be collected for autologous and allogeneic stem cell transplantation.",
  "synonyms": [
    "GRO-beta",
    "GROb"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/cxcr2-agonist-mgta-145/"
}

Record 5,542 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.